2-4 mg of terlipressin: Clinical Trials

1 trial of 2-4 mg of terlipressin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1

Follow 2-4 mg of terlipressin: new trials by email Literature Review of 2-4 mg of terlipressin trials Research Report on 2-4 mg of terlipressin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction
2-4 mg of terlipressin, 3 mg of somatostatin - Liver Cirrhosis
Not applicableNot yet recruitingGeneral Hospital of Shenyang Military Region642026-09-252026-08-27

Conditions studied

Acute Kidney Injury (1)  ·  Liver Cirrhosis (1)  ·  Renal Insufficiency (1)

Sponsors

General Hospital of Shenyang Military Region (1)

Countries

China (1)

Top investigators

Qianqian Li (1)  ·  Rong Li (1)  ·  Xingshun Qi, MD (1)

Results publications

PMID 1350562, PMID 30508958, PMID 32860184, PMID 38161497